A Photoswitchable Tryptophan Zipper – (Un)folding Fibrils in Seconds

22 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Peptides and proteins, that have the tendency to form aggregates, are often discussed in the context of Alz-heimer’s, Huntington’s, or Parkinson’s disease. However, studying aggregation processes is inherently challenging due to the due to the diversity of aggregate size and geometry and the lack of control over the aggregation process in space and time. Here, we present a small, synthetic peptide, for which aggregation can be controlled reversibly with light within seconds. Specifically, by incorporating photoswitchable unnatural amino acids into the sequence of a tryptophan zipper, we could cre-ate the A3Tz5 peptide, which can switch its secondary structure between a β-hairpin and a β-sheet-like structure through photoisomerization. We provide a detailed insight into the molecular interactions involved in this process by combining var-ious spectroscopies and microscopy techniques. With A3Tz5 in hand, we overcame the limitation of spatiotemporal control in aggregation processes opening the door towards disease relevant studies.

Keywords

Tryptophan Zipper
Photoswitches
Unnatural Amino Acids
Aggregation

Supplementary materials

Title
Description
Actions
Title
Supporting
Description
Synthetic procedures, compound characterization, detailed de-scripting and further data regarding UV-Vis and NMR charac-terization, materials, and methods are supplied as Supporting Information.
Actions
Title
Video of photoswitchable reversible aggregation
Description
Recorded on a digital microscope, 10 s blue, then alterning 10s UV and 20s blue (as described in SI).
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.